Although measurement of tumor burden using a veterinary caliper revealed no significant difference, the synergistically therapeutic effect of CD and IFN-β was confirmed through bioluminescence imaging or analysis of survival rate in the mouse model. This evidence concerns the gene IFNB1 and neoplasm.